Oryzon Genomics Market Cap

Oryzon Genomics has a market cap or net worth of 158.63 million as of February 21, 2025. Its market cap has increased by 63.39% in one year.

Market Cap

158.63M

Enterprise Value

165.23M

Revenue

11.81M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.91

Market Cap Chart

Since December 14, 2015, Oryzon Genomics's market cap has increased from 88.97M to 158.63M, an increase of 78.29%. That is a compound annual growth rate of 6.49%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	158.63M	111.73%
Dec 31, 2024	74.92M	-20.63%
Dec 29, 2023	94.39M	-20.04%
Dec 30, 2022	118.04M	-1.22%
Dec 30, 2021	119.51M	-36.52%
Dec 31, 2020	188.26M	75.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
GSK plc	58.67B
Haleon	35.36B
Smith & Nephew	8.91B
Hikma Pharmaceuticals	5.06B
ConvaTec Group	5.01B
HUTCHMED (China)	1.98B
Oxford Nanopore Technologies	1.24B

Market Cap Rankings